Suchergebnisse - "QALYs"

PubPharm (93)

1

Cost-effectiveness of mepolizumab for severe eosinophilic asthma in China

enthalten in: The Journal of asthma : official journal of the Association for the Care of Asthma | 2024

von Chaogang, X. | Mengna, A. | Zhen, W. | +8

2

Arthroscopic Bankart repair versus nonoperative management for first-time anterior shoulder instability : A cost-effectiveness analysis

enthalten in: Shoulder & elbow | 2024

von Li, Z. | Hurley, E. | Garra, S. | +7

3

A nationwide multicenter study of the cost effectiveness of five leading drugs for pharmacological management of cervicobrachial symptoms

enthalten in: Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association | 2023

von Wakao, N. | Furuya, T. | Yoshii, T. | +31

4

Economic evaluations of 13-valent pneumococcal conjugate vaccine : a systematic review

enthalten in: Expert review of vaccines | 2023

von Du, Y. | Wang, Y. | Zhang, T. | +9

5

Cost-Effectiveness of Dapagliflozin for Chronic Kidney Disease in Japan

enthalten in: Circulation journal : official journal of the Japanese Circulation Society | 2022

von Kodera, S. | Morita, H. | Nishi, H. | +3

6

Use of the incremental cost-effectiveness ratio for decision-making policies-what is the problem? A perspective paper

enthalten in: Expert review of pharmacoeconomics & outcomes research | 2022

von Brougham, M. | Schlander, M. | Telser, H. | +2

ErratumIn: Expert Rev Pharmacoecon Outcomes Res. 2022 Jul 21;:1. - PMID 35861375

7

Financial Sustainability of Neuromodulation for Pain

enthalten in: Neurosurgery clinics of North America | 2022

von Schwalb, J.

8

Psychometric properties of the PROMIS Preference score (PROPr) in patients with rheumatological and psychosomatic conditions

enthalten in: BMC rheumatology | 2022

von Klapproth, C. | Fischer, F. | Merbach, M. | +2

9

Psychometric properties of the PROMIS Preference score (PROPr) in patients with rheumatological and psychosomatic conditions

enthalten in: BMC Rheumatology | 2022

von Klapproth, C. | Fischer, F. | Merbach, M. | +2

10

First-line sintilimab plus chemotherapy in locally advanced or metastatic esophageal squamous cell carcinoma : A cost-effectiveness analysis from China

enthalten in: Frontiers in pharmacology | 2022

von Shen, J. | Du, Y. | Shao, R. | +1

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]